Fire Ant Alate Wing Motion Data and Numerical Reconstruction

The wing motions of a male and a female fire ant alate, which beat their wings at 108 and 96 Hz, respectively, were captured with a stereo imaging system at a high frame rate of 8,000 frames per second. By processing the high-speed image frames, the three-dimensional wingtip positions and the wing surface orientation angles were determined with a high phase resolution, i.e. 74 and 83 phases per period for the male and the female, respectively. A numerical reconstruction of the stereo wingbeat images demonstrated that the data collected described almost all the details of the wing surface motion, so that further computational fluid dynamic simulations are possible for fire ant alate flight

Patients receiving opioid maintenance treatment in primary care: successful chronic hepatitis C care in a real world setting

BACKGROUND: Injection drug users (IDUs) represent a significant proportion of patients with chronic hepatitis C (CHC). The low treatment uptake among these patients results in a low treatment effectiveness and a limited public health impact. We hypothesised that a general practitioner (GP) providing an opioid maintenance treatment (OMT) for addicted patients can achieve CHC treatment and sustained virological response rates (SVR) comparable to patients without drug dependency. METHODS: Retrospective patient record analysis of 85 CHC patients who received OMT for more than 3 months in a single-handed general practice in Zurich from January 1, 2002 through May 31, 2008. CHC treatment was based on a combination with pegylated interferon and ribavirin. Treatment uptake and SVR (undetectable HCV RNA 6 months after end of treatment) were assessed. The association between treatment uptake and patient characteristics was investigated by multiple logistic regression. RESULTS: In 35 out of 85 CHC patients (52 males) with a median (IQR) age of 38.8 (35.0-44.4) years, antiviral therapy was started (41.2%). Median duration (IQR) of OMT in the treatment group was 55.0 (35.0-110.1) months compared to the group without therapy 24.0 (9.8-46.3) months (p<0.001). OMT duration remained a significant determinant for treatment uptake when controlled for potential confounding. SVR was achieved in 25 out of 35 patients (71%). CONCLUSION: In addicted patients a high CHC treatment and viral eradication rate in a primary care setting in Switzerland is feasible. Opioid substitution seems a beneficial framework for CHC care in this "difficult to treat" population